TheEdgeResearch
Home / Stocks / RSLBF

RaySearch Laboratories AB (publ) (RSLBF)

OTC Healthcare Medical - Healthcare Information Services
$18.85 ▲ +0.00%
Market Cap
$639.1M
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Beta
0.98
52-Wk Range
16.85-30.75
CEO
Johan Lof
Country
SE
Currency
USD

RaySearch Laboratories AB (publ) operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Stockholm, AB, SE. The stock last traded at $18.85, up 0.00% on the session, giving a market capitalisation of $639.1M. On trailing twelve-month figures it carries a trailing P/E of 29.16, a net margin of 17.2%. Its beta of 0.98 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
29.16
Price / Sales
4.96
Price / Book
6.27
EV / EBITDA
15.06
Gross margin
81.4%
Operating margin
21.6%
Net margin
17.2%
Return on equity
Debt / equity
0.36
Current ratio
1.79
Dividend yield
2.1%
Payout ratio
45.9%
Company profile
Exchange
Other OTC
Employees
433
IPO date
2015-06-09
Headquarters
Stockholm, AB, SE
About RaySearch Laboratories AB (publ)

RaySearch Laboratories AB (publ) is a global medical technology innovator, dedicated to developing advanced software solutions for cancer treatment. Its flagship product, RayStation, serves as a comprehensive treatment planning platform, integrating sophisticated features such as automated planning, adaptive therapy, multi-criteria optimization, and machine learning. This system ensures swift and precise dose calculations, minimizes exposure to organs-at-risk, and accommodates a wide spectrum of radiation modalities, from cutting-edge proton, carbon ion, and boron neutron capture therapies to conventional VMAT, IMRT, 3D-CRT, virtual simulation, electron beam, stereotactic, and tomotherapy treatments. Complementing this, RayPlan offers a specialized treatment planning system tailored for various conventional radiation therapy techniques, including 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam. For streamlined clinical operations, RayCare provides an oncology information system designed to manage and support all facets of cancer treatment. The company also offers RayCommand, a treatment control system engineered for broad hardware compatibility and to leverage the advanced functionalities of treatment machinery. Furthermore, RayIntelligence is a cloud-based oncology analytics platform that transforms complex patient data into valuable, actionable insights. RaySearch also provides educational programs and training to facilitate optimal utilization of its software suite. The company maintains its primary operational base in Stockholm, Sweden.

Comparable companies

RaySearch Laboratories AB (publ) is most often compared with the following Healthcare names:

BIOGYCRWRFLTGHFMDRXNWKHYRHKJFRKAGYSAFLYSMSZFTGLVY
More research on RSLBF
RSLBF technical analysis RSLBF TheEdge Score Compare against peers
Open full interactive analysis & DCF →